IFNG and lung carcinoma: By using lung cancer as a proof‐of‐concept model, IFN‐γ and PD‐L1 siRNA were applied as therapeutic molecules for restoring the tumor‐killing function of immune cells, including macrophages and T cells, which play crucial roles in eliminating tumor cells.